Meridian Bioscience Revogene C. difficile, in vitro diagnostic assay intended for use with recall — FDA Z-1019-2026
The affected lots show a decline in performance over time, which may lead to false-negative results.
Overview of recall records associated with Meridian Bioscience Inc., including dates, categories and classifications where available.
Classification mix: Class II: 1.
The affected lots show a decline in performance over time, which may lead to false-negative results.
This page summarizes recall records in which the official source identifies Meridian Bioscience Inc. as the recalling firm or manufacturer. The number of records should not be treated as a safety rating or a measure of company size, because recall counts depend on product mix, reporting periods and how government records are organized.
Compare the dates, categories and classifications together rather than relying on the total alone. Open an individual record for the recalled product, reason, distribution details and current instructions available from the source.